Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and Efficacy

Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and Efficacy

Live attenuated, cold-adapted (ca) monovalent and bivalent influenza A vaccines were evaluated in seronegative infants (ages 6–18 months) in a double-blind placebo-controlled trial to assess safety and immunogenicity. A total of 182 seronegative subjects received a single intranasal dose (106.2 TCID...

Saved in:

书目详细资料
Main Authors:	William C. Gruber, Robert B. Belshe, James C. King, John J. Treanor, Pedro A. Piedra, Peter F. Wright, George Reed, Elizabeth M. Anderson, Frances K. Newman
格式:	Artigo
语言:	英语
出版:	1996
在线阅读:	https://doi.org/10.1093/infdis/173.6.1313 https://academic.oup.com/jid/article-pdf/173/6/1313/3284622/173-6-1313.pdf
标签:	添加标签没有标签, 成为第一个标记此记录!

相似书籍

Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children
由: Stan L. Block, et al.
出版: (2012)

Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
由: Belshe, R B, et al.
出版: (2001)

Prevention of otitis media in children with live attenuated influenza vaccine given intranasally
由: Robert B. Belshe, et al.
出版: (2000)

Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus Vaccine
由: Robert B. Belshe, et al.
出版: (2000)

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age
由: Belshe, Robert B., et al.
出版: (2010)

The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children
由: Robert B. Belshe, et al.
出版: (1998)

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing
由: Ambrose, C. S., et al.
出版: (2012)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
由: Sobhanie, Mahdee, et al.
出版: (2016)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
由: Mahdee Sobhanie, et al.
出版: (2015)

Complexities in Predicting the Immunogenicity of Live Attenuated Influenza Vaccines
由: Lindsey, Benjamin B, et al.
出版: (2020)

A Live Attenuated Equine H3N8 Influenza Vaccine Is Highly Immunogenic and Efficacious in Mice and Ferrets
由: Baz, Mariana, et al.
出版: (2014)

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults
由: Robert B. Belshe, et al.
出版: (2007)

Comparative Immunogenicity of Trivalent Influenza Vaccine Administered by Intradermal or Intramuscular Route in Healthy Adults
由: Belshe, Robert B., et al.
出版: (2007)

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults
由: Ambrose, Christopher S., et al.
出版: (2010)

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults
由: Christopher S. Ambrose, et al.
出版: (2010)

Live Attenuated and Inactivated Influenza Vaccines in Children
由: Ilyushina, Natalia A., et al.
出版: (2015)

Live Attenuated and Inactivated Influenza Vaccines in Children
由: Natalia A. Ilyushina, et al.
出版: (2014)

Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold‐Adapted, Administered to Human Immunodeficiency Virus (HIV)–Infected and Non–HIV‐Infected Adults
由: James C. King, et al.
出版: (2000)

Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants
由: Ruth A. Karron, et al.
出版: (2005)

No Clinical Association of Live Attenuated Influenza Virus with Nasal Carriage of Bacteria or Acute Otitis Media
由: Coelingh, Kathleen L., et al.
出版: (2014)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
由: Roy, Sreeja, et al.
出版: (2020)

A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children
由: Caspard, Herve, et al.
出版: (2016)

Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial
由: Piedra, Pedro A., et al.
出版: (2005)

Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial
由: Pedro A. Piedra, et al.
出版: (2005)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
由: Wright, Peter F., et al.
出版: (2016)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
由: Peter F. Wright, et al.
出版: (2016)

Serum Antibody Responses after Intradermal Vaccination against Influenza
由: Robert B. Belshe, et al.
出版: (2004)

Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age
由: Malkin, Elissa, et al.
出版: (2013)

Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age
由: Elissa Malkin, et al.
出版: (2013)

Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults
由: Eiden, Joseph, et al.
出版: (2021)

Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
由: Robert B. Belshe, et al.
出版: (2007)

160. Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age
由: Chang, Leejah, et al.
出版: (2020)

Comparative Immunogenicities of Frozen and Refrigerated Formulations of Live Attenuated Influenza Vaccine in Healthy Subjects
由: Block, Stan L., et al.
出版: (2007)

Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.
由: Gorse, G J, et al.
出版: (1988)

Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.
由: Ray, R, et al.
出版: (1995)

Safety and Immunogenicity of a Subvirion Inactivated Influenza A/H5N1 Vaccine with or without Aluminum Hydroxide Among Healthy Elderly Adults
由: Brady, Rebecca C., et al.
出版: (2009)

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
由: John J. Treanor, et al.
出版: (1999)

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
由: John J. Treanor, et al.
出版: (2006)

Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults
由: Daniel F. Hoft, et al.
出版: (2016)

Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model
由: Stepanova, Ekaterina, et al.
出版: (2021)